When we reclassified our patients as per the contemporary WHO definition of MDS/MPN-RS-T, only Hb ≤10 gm/dL and abnormal karyotype (without -Y) retained independent prognostic significance. This evidence concerns the gene GSTM1 and myeloproliferative disorder.